ATLAS ANTIBODIES Trademark

Trademark Overview

On Tuesday, January 22, 2013, a trademark application was filed for ATLAS ANTIBODIES with the United States Patent and Trademark Office. The USPTO has given the ATLAS ANTIBODIES trademark a serial number of 85828692. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, August 29, 2024. This trademark is owned by Atlas Antibodies AB. The ATLAS ANTIBODIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnostics, prognostics, and treatment

Scientific and medical research and developments within the field of biochemistry and biotechnology, diagnostics and pharmaceutical or medical substances and preparations
atlas antibodies

General Information

Serial Number85828692
Word MarkATLAS ANTIBODIES
Filing DateTuesday, January 22, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, August 29, 2024
Registration Number4556814
Registration DateTuesday, June 24, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements

Description of MarkThe mark consists of the words "ATLAS ANTIBODIES" with a figurative design element of a man to the left of the words.
Goods and ServicesPharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnostics, prognostics, and treatment
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"ANTIBODIES"
Goods and ServicesScientific and medical research and developments within the field of biochemistry and biotechnology, diagnostics and pharmaceutical or medical substances and preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 25, 2013
Primary Code005
First Use Anywhere DateWednesday, March 13, 2013
First Use In Commerce DateThursday, March 14, 2013
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 25, 2013
Primary Code042
First Use Anywhere DateWednesday, March 13, 2013
First Use In Commerce DateThursday, March 14, 2013

Trademark Owner History

Party NameAtlas Antibodies AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStockholm SE-113 63
SE
Party NameAtlas Antibodies AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStockholm 10691
SE
Party NameAtlas Antibodies AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStockholm 10691
SE

Trademark Events

Event DateEvent Description
Sunday, May 5, 2013ASSIGNED TO EXAMINER
Friday, January 25, 2013NEW APPLICATION ENTERED
Friday, January 25, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 26, 2013NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, May 14, 2013SUSPENSION LETTER WRITTEN
Tuesday, May 14, 2013LETTER OF SUSPENSION E-MAILED
Tuesday, May 14, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 11, 2013TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, October 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 29, 2013ASSIGNED TO LIE
Tuesday, December 3, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 7, 2014TEAS STATEMENT OF USE RECEIVED
Monday, April 7, 2014USE AMENDMENT FILED
Friday, April 25, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 28, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, May 19, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 21, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, May 22, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 24, 2014REGISTERED-PRINCIPAL REGISTER
Monday, June 24, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 10, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 10, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 8, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, April 2, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, May 30, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 1, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, July 9, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 24, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 15, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, February 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, July 9, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 10, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, April 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 17, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, August 29, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 29, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, August 29, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, August 29, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Related Keywords

antibodies atlas pharmaceutical diagnostics preparations cancer medical vivo prognostics treatment substances immunoglobulin